Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2009
10/29/2009US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009US20090270314 Polypeptide having anti-angiogenic activity
10/29/2009US20090269427 Herbal composition for inflammatory disorders
10/29/2009US20090269423 chinese herbal foot-bathing agent for treating hypertension and improving sleep quality, includes fructus leonuri 20-25%, semen ziziphi spinosae 15-20%, calcined magnetitum 17-22%, spica prunellae 15-20%, ligusticum chuanxiong hort 18-23%, and borneolum 0.7-1.2% by weight in the form of mixed powder
10/29/2009US20090269415 Novel therapeutic agent derived from marine organism
10/29/2009US20090269362 Method for Controlling Immunodominance
10/29/2009US20090269361 Constructs for delivery of therapeutic agents to neuronal cells
10/29/2009US20090269302 Human antibodies that bind human il-12 and methods for producing
10/29/2009US20090269301 Novel Inhibitors of Glutaminyl Cyclase
10/29/2009CA2723222A1 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
10/29/2009CA2722371A1 Use of epothelone d in treating tau-associated diseases including alzheimer's disease
10/29/2009CA2722325A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009CA2722255A1 Inhibitors of ikk-.beta. serine-threonine protein kinase
10/29/2009CA2722246A1 Nalmefene prodrugs
10/29/2009CA2722243A1 Nalmefene di-ester prodrugs
10/29/2009CA2722041A1 Novel five-membered ring compound
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2721952A1 Retinal pigment epithelial stem cells
10/29/2009CA2721919A1 Limk2 inhibitors, compositions comprising them, and methods of their use
10/29/2009CA2721910A1 Cyclobutyl sulfones as notch sparing gamma secretase inhibitors
10/29/2009CA2721908A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
10/29/2009CA2721835A1 Methods for radiolabelling synthetic polymers
10/29/2009CA2721738A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2721542A1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
10/29/2009CA2721260A1 Isoquinolinone derivatives as nk3 antagonists
10/29/2009CA2720994A1 Therapeutic use of botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
10/29/2009CA2720659A1 1-(7-(hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)quinolin-4-yl)-3-(pyrazin-2-yl)urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
10/28/2009EP2112234A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/28/2009EP2112145A1 Chromenone derivatives useful for the treatment of neurodegenerative diseases
10/28/2009EP2112142A1 Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
10/28/2009EP2111864A2 Therapeutic methods and uses of sapogenins and their derivatives
10/28/2009EP2111862A1 Pharmaceutical product for prevention and treatment of alzheimer's dementia
10/28/2009EP2111858A1 Novel treatment for alzheimer's disease
10/28/2009EP2111394A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
10/28/2009EP2111262A2 1,3-dihydroimidazoles for treating cardiovascular disorders
10/28/2009EP1734959B1 Compounds for treating schizophrenia and/or glucoregulatory abnormalities
10/28/2009EP1732557B1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
10/28/2009EP1656122B1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
10/28/2009EP1624936B1 Cns chloride modulation and uses thereof
10/28/2009EP1620182B1 Methods for treating sinus headache
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009CN101568541A Spirocyclic azaadamantane derivatives and methods of use
10/28/2009CN101568536A 2-aza-bicyclo[3.1.0]hexane derivatives
10/28/2009CN101568533A 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors
10/28/2009CN101568531A Polymorphs of a mglur5 receptor antagonist
10/28/2009CN101568524A Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
10/28/2009CN101568362A Methods for treating depression
10/28/2009CN101568340A Percutaneous absorption preparation
10/28/2009CN101568333A Treatment of pervasive developmental disorders
10/28/2009CN101568330A Methods for the preparation of biologically active compounds in nanoparticulate form
10/28/2009CN101565420A LIMK2 inhibitors, compositions comprising them, and methods of their use
10/28/2009CN101565419A 7 and 20 dehydro-silybin dialky ether and preparation method and medicine use thereof
10/28/2009CN101565408A Receptor signal transduction positive modulator, preparation method and purpose thereof
10/28/2009CN101564530A Application of Buthus martensii Karsch Martentoxin
10/28/2009CN101564513A Medicament for treating epilepsy and preparation method thereof
10/28/2009CN101564509A Medicament for treating early encephalitis B
10/28/2009CN101564508A Medicinal tea for preventing encephalitis and preparation method thereof
10/28/2009CN101564507A Medicament for preventing encephalitis
10/28/2009CN101564502A Oral liquid for treating cerebral palsy and preparation method thereof
10/28/2009CN101564495A Series medicaments for psychosis negative four-step therapy
10/28/2009CN101564494A Composition for nourishing kidney, tonifying energy, nourishing brain and allaying excitement, preparation method and quality control method
10/28/2009CN101564485A Chinese herbal medicine formula for curing sciatic neuralgia and preparation method thereof
10/28/2009CN101564478A Medicament for treating peripheral facial paralysis and preparing method thereof
10/28/2009CN101564470A Oral liquid for improving body hypoxia-bearing capability and enhancing memory function and process
10/28/2009CN101564445A Preparation method for medicament treating infantile convulsion
10/28/2009CN101564439A Application of Chinese medicinal composition in preparation of medicament for treating epilepsy
10/28/2009CN101564432A Health tea for curing the insomnia of middle-aged and old people
10/28/2009CN101564388A Composition for Danshensu and danshinolic acid B and use thereof
10/28/2009CN101564180A Walnut total nutriment and soft capsule and health products containing same
10/28/2009CN100554410C Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/28/2009CN100554266C Aryl piperazine modified benzo [b] thiophene compound, and its preparing method and use
10/28/2009CN100554264C Pyrazolyl and imidazolyl pyrimidines
10/28/2009CN100554259C 2-benzo(C) foroxone compound, its production and use
10/28/2009CN100554247C Muscarinic agonists
10/28/2009CN100554244C New mao-b inhibitors
10/28/2009CN100553672C Freeze-dried powder injection for injection for brain refreshment and its preparing method
10/28/2009CN100553658C Medication for treating dementia and preparation method
10/28/2009CN100553655C Chinese traditional medicine good for heart and brain
10/28/2009CN100553653C Combination of Chinese traditional medicine for treating insomnia
10/28/2009CN100553652C Medication for treating insomnia
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/28/2009CN100553623C Chinese caterpillar fungus formulation preparation method
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608636 Medicines for treatment and prevention of neurogenic pain
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608629 Useful for the treatment of migraine and other 5-HT1F receptor associated disorders; for example, N-[3-(1-methyl-piperidin-4-yloxy)-phenyl]-2-furancarboxamide
10/27/2009US7608624 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
10/27/2009US7608577 Peptidyl ketones as inhibitors of DPIV
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
10/27/2009US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 1833